US FDA Safety Labeling Change for mRNA COVID-19 Vaccines

This Viewpoint explores the US Food and Drug Administration’s institution of a class Safety Labeling Change for messenger RNA (mRNA) COVID-19 vaccines.

Authors

Martin A. Makary (ORCID: https://orcid.org/0000-0001-6091-4929)
Vinay Prasad (ORCID: https://orcid.org/0000-0002-6110-8221)

Institutions

United States Food and Drug Administration (US)

Publication Details

Journal: JAMA
Published: 2025-07-14
DOI: https://doi.org/10.1001/jama.2025.12675
Citations: 5
Primary Topic: Viral Infections and Immunology Research
Type: article
Field-Weighted Citation Impact: 6.94

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

US FDA Safety Labeling Change for mRNA COVID-19 Vaccines

Martin A. Makary, Vinay Prasad

Jul 14, 2025

5 citations

JAMA

Viral Infections and Immunology Research

6.94

article

US FDA Safety Labeling Change for mRNA COVID-19 Vaccines

Martin A. Makary, Vinay Prasad

July 14, 2025article en

5 citations

Abstract

This Viewpoint explores the US Food and Drug Administration’s institution of a class Safety Labeling Change for messenger RNA (mRNA) COVID-19 vaccines.

JAMAVol. 334(11)

United States Food and Drug Administration (US)

Zero hunger

Openalex Percentile: Top 3%

Viral Infections and Immunology Research

6.94

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

US FDA Safety Labeling Change for mRNA COVID-19 Vaccines — Martin A. Makary, Vinay Prasad · JAMA (2025) | TGRS Research Map | TGRS